Skip to main navigation Skip to search Skip to main content

Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients

  • Qing Liu
  • , Luke B. Hesson
  • , Andrea C. Nunez
  • , Deborah Packham
  • , Nicholas J. Hawkins
  • , Robyn L. Ward
  • , Mathew A. Sloane

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Lynch syndrome is a hereditary cancer syndrome caused by the autosomal dominant inheritance of loss-of-function mutations in DNA mismatch repair (MMR) genes. Approximately one quarter of clinically suspected cases have no identifiable germline mutation in any MMR gene, a condition known as Lynch-like syndrome (LLS). MCM9 was recently identified as the DNA helicase in the mammalian MMR complex and loss of helicase activity results in microsatellite instability. We hypothesized that pathogenic variants in MCM9 may account for LLS. The 5′UTR and coding region of MCM9 were sequenced in germline DNA of 109 Australian patients with LLS and variants were cross-referenced with three population-based databases (dbSNP144, 1000 Genomes, ExAC). The functional effect of variants was assessed in silico with PolyPhen-2, SIFT and CONDEL. Fifteen variants that included six common SNPs and nine variants of unknown significance (VUS) were identified. We conclude that VUS occur in MCM9 in a small proportion of LLS patients and MCM9 mutations are unlikely to explain most LLS cases.

Original languageEnglish
Pages (from-to)497-500
Number of pages4
JournalCancer Genetics
Volume209
Issue number11
DOIs
Publication statusPublished - Nov 2016
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • DNA mismatch repair
  • helicase
  • Lynch syndrome
  • Lynch-like syndrome
  • MCM9

Cite this